Digital Goa, Sept 14- Goa FDA has warned the local unit of antacid drug manufacturer of suspending the manufacturing license of its popular antacid medicine after inspectors flagged contamination risks and sanitization issues at its factory. The drugmaker had voluntarily recalled many batches of its antacid Gel syrup produced in Goa after it received customer complaints on taste and odor. The manufacturer said there is no impact on patient health. Following the recall, FDA inspectors conducted four inspections at the Goa based factory between Aug 24 and Sept 2 and are said to have flagged issues such as water stagnation in tanks and pipes. Following this the company has been issued a warning notice by FDA on Sept 11 stating that it intend to cancel the product permission for all variants of antacid or suspend the licenses held by the company for a period deemed fit.
